Chantix Tagged Articles
Anti-smoking drug Chantix may help other addicts, but at what cost?
Two new clinical studies have found evidence that Pfizers’s anti-smoking drug Chantix (varenicline) may help take the enjoyment out of cocaine and alcohol in much the same way it makes smoking cigarettes feel less desirable, thereby easing addiction and making
UC doctor finds statin drugs may cause anger, hostility in rare cases
Some people taking Pfizer’s smoking-cessation drug Chantix have reportedly experienced fits of hostility. Anti-depression medications and other drugs that work to modify brain activity have also been linked to episodes of violent behavior. But what about statins, the drugs commonly
Chantix risks are far greater than other stop-smoking drugs, new study finds
The authors of a study published Wednesday in the science and medical journal PLoS One say that Pfizer’s smoking cessation drug Chantix “shows a substantial, statistically significant increased risk of reported depression and suicidal/self-injurious behavior” than other smoking cessation drugs
Chantix significantly increases cardiovascular risks, according to another new study
Last month, the Food and Drug Administration warned of newly discovered cardiovascular risks associated with Pfizer’s popular smoking-cessation drug Chantix. But it turns out those risks, which include higher occurrence of heart attack and other adverse cardiovascular events in Chantix
FDA warns of new heart risks associated with Chantix
For many smokers trying to kick their addiction, the latest news about the dangers of Pfizer’s smoking-cessation drug Chantix presents as a damned if you do, damned if you don’t dilemma. The U.S. Food and Drug Administration issued an alert
Chantix suicides and violence much more common, newly found reports show
A senior scientist working for the non-profit Institute for Safe Medicine Practices has discovered that Chantix is a much more dangerous drug than has been officially acknowledged after finding hundreds of serious adverse reactions were reported to the FDA by
New warnings for off-label smoking addiction drug Aplenzin
The antidepressant Aplenzin (bupropion hydrobromide) extended-release tablets has a new black box warning against the use of the drug to help people quit smoking. The drug is approved by the Food and Drug Administration (FDA) only for the treatment of
Health Canada issues stronger warnings about Champix,Chantix
Health Canada has ordered Pfizer Canada to issue stronger warnings about its smoking cessation medication Champix, also known as Chantix in the United States, because of numerous reports of serious neuropsychiatric symptoms and some cases of the potentially fatal skin
